Merit Medical Systems, Inc. MMSI

87.50 0.20 0.23% as of 25 Sep
Market cap
$5.2B
P/E
35.7×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Revenue
1,515.91 1,356.51 1,257.37 1,150.98 1,074.75 963.88 994.85 882.75 727.85 603.84
Revenue Growth
11.75% 7.89% 9.24% 7.09% 11.50% (3.11%) 12.70% 21.28% 20.54% 11.38%
Cost of Revenue
777.64 713.18 673.49 631.88 589.42 562.70 562.49 487.98 401.60 338.81
Gross Profit
738.27 643.33 583.87 519.10 485.33 401.18 432.37 394.77 326.25 265.03
R&D Expenses
97.35 87.47 82.73 75.51 71.25 57.54 65.62 59.53 51.40 45.23
SG&A Expenses
455.21 399.73 373.68 342.53 335.69 297.72 327.27 276.02 229.13 184.40
Operating Income
184.72 155.69 123.94 87.56 60.92 (1.56) 15.43 58.62 33.07 34.88
Non-operating Income/Expense
(13.78) (5.70) (11.85) (4.93) (7.00) (11.67) (13.24) (9.10) 2.81 (9.49)
Non-operating Interest Expenses
26.46 31.22 15.51 6.34 5.26 9.99 12.41 10.36 7.74 8.80
EBT
170.94 149.99 112.09 82.63 53.92 (13.23) 2.19 49.52 35.88 25.39
Income Tax Provision
42.45 29.64 17.68 8.11 5.46 (3.39) (3.26) 7.50 8.36 5.27
Income after Tax
128.49 120.36 94.41 74.52 48.45 (9.84) 5.45 42.02 27.52 20.12
Dividends (Preferred)
— 0.00 0.00 — — — — 0.00 — —
Net Income Common
128.49 120.36 94.41 74.52 48.45 (9.84) 5.45 42.02 27.52 20.12
EPS (Basic)
2.17 2.07 1.64 1.31 0.86 (0.18) 0.10 0.80 0.56 0.45
EPS (Diluted)
2.13 2.03 1.62 1.29 0.84 (0.18) 0.10 0.78 0.55 0.45
Shares (Basic, Weighted)
59.16 58.22 57.59 56.81 56.15 55.43 55.08 52.27 48.81 44.41
Shares (Diluted, Weighted)
60.46 59.37 58.36 57.67 57.36 55.43 56.24 53.93 50.10 44.86
Gross Margin
48.70% 47.43% 46.44% 45.10% 45.16% 41.62% 43.46% 44.72% 44.82% 43.89%
EBIT Margin
12.19% 11.48% 9.86% 7.61% 5.67% (0.16%) 1.55% 6.64% 4.54% 5.78%
EBT margin
11.28% 11.06% 8.91% 7.18% 5.02% (1.37%) 0.22% 5.61% 4.93% 4.20%
Net Profit Margin
8.48% 8.87% 7.51% 6.47% 4.51% (1.02%) 0.55% 4.76% 3.78% 3.33%
Free Cash Flow Margin
14.02% 13.47% 8.63% 5.75% 10.93% 12.04% (0.28%) 2.29% 2.96% 3.07%
EBITDA
324.92 277.09 226.85 180.26 157.20 105.73 120.37 128.83 87.19 79.41
EBIT
184.72 155.69 123.94 87.56 60.92 (1.56) 15.43 58.62 33.07 34.88
Income from Continuous Operations
128.49 120.36 94.41 74.52 48.45 (9.84) 5.45 42.02 27.52 20.12
Consolidated Net Income/Loss
128.49 120.36 94.41 74.52 48.45 (9.84) 5.45 42.02 27.52 20.12
EPS (Basic, from Continuous Ops)
2.17 2.07 1.64 1.31 0.86 (0.18) 0.10 0.80 0.56 0.45
EPS (Basic, Consolidated)
2.17 2.07 1.64 1.31 0.86 (0.18) 0.10 0.80 0.56 0.45
EPS (Diluted, from Cont. Ops)
2.13 2.03 1.62 1.29 0.84 (0.18) 0.10 0.78 0.55 0.45
Shares (Diluted, Average)
60.46 59.37 58.36 57.67 57.36 55.43 56.24 53.93 50.10 44.86
EPS (Diluted, Consolidated)
2.13 2.03 1.62 1.29 0.84 (0.18) 0.10 0.78 0.55 0.45
EBITDA Margin
21.43% 20.43% 18.04% 15.66% 14.63% 10.97% 12.10% 14.59% 11.98% 13.15%
Operating Cash Flow Margin
19.62% 16.28% 11.54% 9.93% 13.70% 17.15% 7.82% 9.80% 8.62% 8.88%

Fold the line items

In millions of $ except per-share values · columns are period end dates